Life Sciences

IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery

Share this post:

 

Watson Health and Pfizer Inc. today announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer’s research in immuno-oncology, an approach to cancer treatment that uses the body’s immune system to help fight cancer. Pfizer is one of the first organizations worldwide to deploy Watson for Drug Discovery, and the first to customize the cloud-based cognitive tool – tapping into Watson’s machine learning, natural language processing, and other cognitive reasoning technologies to support the identification of new drug targets, combination therapies for study, and patient selection strategies in immuno-oncology.

More Life Sciences stories

Watson Health success story – California’s Valued Trust

Written by Watson Health | Value-Based Care, Video

Watson Health helps to support the mission of California's Valued Trust by providing the underlying analytic architecture needed to understand what’s driving cost and trend in various regions. ...read more


Health Quest Medical Practice – Patient outreach

Written by Watson Health | Value-Based Care, Video

Hear members of the Health Quest Medical Practice team explain how they use IBM Watson Health solutions to close care gaps and target patient outreach. ...read more


Health Quest Medical Practice – Near real-time data

Written by Watson Health | Value-Based Care, Video

Health Quest Medical Practice uses Watson Health solutions to supplement the information in their EHR. Learn how access to enhanced data has helped close patient care gaps and track quality measures. ...read more